Neurological disorders are diseases of the central nervous system (CNS), characterized by
a progressive degeneration of cells and deficiencies in neural functions. Mesenchymal stem …

Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD),
Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic …

Spinal cord injury (SCI) disrupts the blood–spinal cord barrier (BSCB), potentially
exacerbating nerve damage and emphasizing the criticality of preserving the BSCB integrity …

Neurodegenerative diseases are fatal disorders of the central nervous system (CNS) which
currently lack effective treatments. The application of mesenchymal stem cells (MSCs) …

Vascular injury following spinal cord injury (SCI) can significantly exacerbate secondary SCI
and result in neurological dysfunction. Strategies targeting angiogenesis have demonstrated …

Multiple Sclerosis (MS) is a chronic demyelinating autoimmune disease primarily affecting
young adults. Despite an unclear causal factor, symptoms and pathology arise from the …

Experimental autoimmune encephalomyelitis (EAE) is a mouse model for the human
multiple sclerosis, which is characterized by inflammation in the central nervous system …

Multiple Sclerosis (MS) is a chronic inflammatory neurodegenerative disease of central
nervous system (CNS). Although the main cause of MS is not clear, studies suggest that MS …

The clinical translation of stem cells and their extracellular vesicles (EVs)-based therapy for
central nervous system (CNS) diseases is booming. Nevertheless, the insufficient CNS …

Background: The convoluted pathophysiology of brain disorders along with penetration
issue of drugs to brain represents major hurdle that requires some novel therapies. The …